Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Become a Member
Explore Different Ways to Give
Create a Legacy
Join IASLC's Partners for Thoracic Cancer Care
Recognizing Our Donors
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Education
Conferences & Education
Conferences
Webinars
Online Learning: Lung Cancer 360
Lung Cancer Considered Podcast
WCLC 2024
Science & Research
Science & Research
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Research Grant Program
Research Grant Program
Research Grant Recipients
IASLC Academy
Publications, Resources & Guidelines
Membership
Membership
Become a Member
Renew Your Membership
Early-Career Opportunities
Partners Society Membership Offers
Patients & Caregivers
Patients & Caregivers
STARS Training
Lung Cancer Awareness Month
News
News
IASLC Lung Cancer News
WCLC 2024 News
Press Releases
Search
Fulltext search
Fulltext search
Search
Displaying 97 - 108 items out of 312 results
ILCN article
Novel Insights on ctDNA Dynamics During Targeted Therapy and Immune Checkpoint Blockage in NSCLC
ILCN article
Lung Cancer Leading the Charge for Tumor-Agnostic Targeted Therapies
ILCN article
Experts Discuss Turnaround Times, Geographic Differences Regarding Liquid Biopsy
ILCN article
Concurrent Chemoradiation Followed by Consolidation Therapy: Questions Remain Despite Transformational Data
ILCN article
Key Findings from the CAR T-Cell Study Presented at the 2019 AACR Annual Meeting
ILCN article
Adjuvant EGFR-TKI for Resected NSCLC: Who, When, and Where?
ILCN article
Antibody–Drug Conjugates in NSCLC: Complexities, Challenges, and Potential
ILCN article
Consolidating Gains with Chemotherapy in SCLC Maintenance Trials: A Discussion with Dr. Shirish Gadgeel
ILCN article
Tackling TKI-Refractory Disease in Patients with Oncogenic Drivers: An Interview with Dr. Mark Socinski
ILCN article
Making Headway with Lorlatinib
ILCN article
Clinical Utility of Plasma Next-Generation Sequencing in Advanced NSCLC: Are We Ready for a ‘Blood-First’ Approach?
ILCN article
KEYNOTE-010: Long-Term Outcomes and Results of Retreatment
Pagination
First
First page
‹
Previous page
…
5
6
7
8
9
10
11
12
13
…
›
Next page
Last
Last page